Copenhagen, Denmark

Peter Kristensen


Average Co-Inventor Count = 21.0

ph-index = 2

Forward Citations = 18(Granted Patents)


Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Kristensen

Introduction: Peter Kristensen, an esteemed inventor based in Copenhagen, Denmark, has made significant strides in biomedical research through his innovations. With a remarkable portfolio comprising two patents, Kristensen has dedicated his work to advancing understanding in the field of plasminogen activation and its implications in cancer research.

Latest Patents: Among his notable inventions are two crucial patents focused on urokinase-type plasminogen activator (uPA) receptors. The first patent addresses the inhibition of plasminogen conversion to plasmin by preventing the binding of urokinase-type plasminogen activator to its receptor in mammals. This innovation could have important implications for therapeutic strategies against conditions like cancer, where plasminogen activation plays a critical role. His second patent similarly revolves around methods and vectors for recombinant production of soluble, active fragments of the uPA receptor, providing essential tools for further research and application in this area.

Career Highlights: Peter Kristensen's career is marked by his association with Cancerforskningsfondet Af 1989, where he has been instrumental in driving research efforts and securing advancements in cancer therapy through innovative approaches. His patents highlight his commitment to translating scientific discoveries into practical solutions that can enhance patient outcomes.

Collaborations: Throughout his career, Kristensen has collaborated with distinguished researchers, including Francesco Blasi and Ann Louring Roldan. These partnerships reflect a synergy of ideas and expertise that further propel the field of cancer research and innovative therapies.

Conclusion: Peter Kristensen's contributions to the scientific community demonstrate the importance of innovation in addressing complex medical challenges. His work with urokinase-type plasminogen activator receptors exemplifies how targeted research can lead to advancements with a potential impact on cancer treatment. As his career progresses, Kristensen continues to inspire future innovations within the biomedical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…